Fig. 3

Association between clinicopathological features, immunohistochemical factors and distant metastasis-free survival over the first 5 years in the Luminal B Her2-negative group of breast cancer patients
Association between clinicopathological features, immunohistochemical factors and distant metastasis-free survival over the first 5 years in the Luminal B Her2-negative group of breast cancer patients